![Nishant Saxena](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 531 278 $ as of 29/09/2026
Nishant Saxena is currently Chief Business Officer at Corbus Pharmaceuticals Holdings, Inc. since 2026.
Formerly, Mr. Saxena was Chief Financial Officer at Jeune Aesthetics, Inc. Education includes undergraduate and MBA degrees from The Wharton School of the University of Pennsylvania.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 10/08/2026 | 77,900 ( 0.4% ) | 531 278 $ | 29/09/2026 |
| Companies | Position | Start |
|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Corporate Officer/Principal | 20/05/2026 |
| Companies | Position | End |
|---|---|---|
Jeune Aesthetics, Inc.
 Jeune Aesthetics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Director of Finance/CFO | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 3 |
|---|---|
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corbus Pharmaceuticals Holdings, Inc.
 Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
Jeune Aesthetics, Inc.
Jeune Aesthetics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
